Skip to main content

Advertisement

Log in

The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease

  • Original Article
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

Prior studies show that left ventricular mechanical dyssynchrony (LVD), measured by gated SPECT myocardial perfusion imaging (MPI), identifies patients with end-stage renal disease (ESRD) at higher risk for all-cause mortality but these were in small number of patients. We sought to assess the interaction between LVD and LV perfusion pattern in risk-stratification of a large sample size of patients with ESRD.

Methods

From the renal transplantation database maintained at the University of Alabama at Birmingham, we identified consecutive patients with ESRD who had gated SPECT MPI between 2003 and 2007. MPIs were reprocessed to derive LV ejection fraction (EF), perfusion defect size, and LVD [phase bandwidth (BW) and phase standard deviation (SD)]. The primary end-point was all-cause mortality, which was prospectively collected and verified against the social security death index database.

Results

There were 828 patients aged 52.6 ± 0.36 years (45% were women and 60% had diabetes mellitus). The LVEF was 54.8 ± 0.4% and the perfusion pattern was abnormal in 334 patients (41%). During a follow-up period of 61 ± 0.9 months, 230 patients (28%) received renal transplants and 290 patients (35%) died. The phase BW (73.1 ± 2.6° vs 66.3 ± 1.8°, P = .02) and SD (25.2 ± 0.8° vs 23.4 ± 0.5°, P = .06) were greater in patients who died than those who survived indicating greater dyssynchrony. Patients with phase BW >56° or SD ≥21° (median values) had worse 5-year survival (64% vs 72%, and 66% vs 71%, log-rank P = .005 and P = .07, respectively). After adjusting for demographics, co-morbidities, LVEF, and perfusion pattern, phase BW was associated with worse outcome (hazard ratio 1.289 95% CI 1.010-1.644, P = .04).

Conclusions

LVD by phase analysis of gated SPECT MPI provides prognostic value in ESRD beyond myocardial perfusion and EF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369:932-43.

    Article  CAS  PubMed  Google Scholar 

  2. Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol. 2009;53:2129-40.

    Article  PubMed  Google Scholar 

  3. United States Renal Data System (USRDS). 2012 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.

  4. Aljaroudi WA, Hage FG, Hermann D, Doppalapudi H, Venkataraman R, Heo J, et al. Relation of left-ventricular dyssynchrony by phase analysis of gated SPECT images and cardiovascular events in patients with implantable cardiac defibrillators. J Nucl Cardiol. 2010;17:398-404.

    Article  PubMed  Google Scholar 

  5. Chen J, Kalogeropoulos AP, Verdes L, Butler J, Garcia EV. Left-ventricular systolic and diastolic dyssynchrony as assessed by multi-harmonic phase analysis of gated SPECT myocardial perfusion imaging in patients with end-stage renal disease and normal LVEF. J Nucl Cardiol. 2011;18:299-308.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Aljaroudi W, Koneru J, Iqbal F, Aggarwal H, Heo J, Iskandrian AE. Left ventricular mechanical dyssynchrony by phase analysis of gated single photon emission computed tomography in end-stage renal disease. Am J Cardiol. 2010;106:1042-7.

    Article  PubMed  Google Scholar 

  7. Murata T, Dohi K, Onishi K, Sugiura E, Fujimoto N, Ichikawa K, et al. Role of haemodialytic therapy on left ventricular mechanical dyssynchrony in patients with end-stage renal disease quantified by speckle-tracking strain imaging. Nephrol Dial Transplant. 2011;26(5):1655-61. doi:10.1093/ndt/gfq590.

    Article  PubMed  Google Scholar 

  8. Aljaroudi W, Aggarwal H, Venkataraman R, Heo J, Iskandrian AE, Hage FG. Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease. J Nucl Cardiol. 2010;17:1058-64.

    Article  PubMed  Google Scholar 

  9. Hage FG, de Mattos AM, Khamash H, Mehta S, Warnock D, Iskandrian AE. QT prolongation is an independent predictor of mortality in end-stage renal disease. Clin Cardiol. 2010;33:361-6.

    Article  PubMed  Google Scholar 

  10. Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol. 2007;100:1020-5.

    Article  PubMed  Google Scholar 

  11. Holly TA, Abbott BG, Al-Mallah M, Calnon DA, Cohen MC, DiFilippo FP, et al. Single photon-emission computed tomography. J Nucl Cardiol. 2010;17:941-73.

    Article  PubMed  Google Scholar 

  12. Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiol. 2011;18:1086-94.

    Article  PubMed  Google Scholar 

  13. Hage FG, Venkataraman R, Aljaroudi W, Bravo PE, McLarry J, Faulkner M, et al. The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. J Nucl Cardiol. 2010;17:378-89.

    Article  PubMed  Google Scholar 

  14. Iskandrian AE. Stress-only myocardial perfusion imaging a new paradigm. J Am Coll Cardiol. 2010;55(3):231-3. doi:10.1016/j.jacc.2009.10.007.

    Article  PubMed  Google Scholar 

  15. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138-47.

    CAS  PubMed  Google Scholar 

  16. Al-Jaroudi W, Iqbal F, Heo J, Iskandrian AE. Relation between heart rate and left ventricular mechanical dyssynchrony in patients with end-stage renal disease. Am J Cardiol. 2011;107:1235-40.

    Article  PubMed  Google Scholar 

  17. Chen J, Garcia EV, Folks RD, Cooke CD, Faber TL, Tauxe EL, et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: Development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol. 2005;12:687-95.

    Article  PubMed  Google Scholar 

  18. Aljaroudi W, Koneru J, Heo J, Iskandrian AE. Impact of ischemia on left ventricular dyssynchrony by phase analysis of gated single photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol. 2011;18(1):36-42. doi:10.1007/s12350-010-9296-1.

    Article  PubMed  Google Scholar 

  19. Venkataraman R, Hage FG, Dorfman T, Heo J, Aqel RA, de Mattos AM, et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography. Am J Cardiol. 2008;102:1451-6.

    Article  PubMed  Google Scholar 

  20. Pazhenkottil AP, Buechel RR, Husmann L, Nkoulou RN, Wolfrum M, Ghadri JR, et al. Long-term prognostic value of left ventricular dyssynchrony assessment by phase analysis from myocardial perfusion imaging. Heart. 2010;97:33-7.

    Article  PubMed  Google Scholar 

  21. AlJaroudi W, Alraies MC, Hachamovitch R, Jaber WA, Brunken R, Cerqueira MD, et al. Association of left ventricular mechanical dyssynchrony with survival benefit from revascularization: A study of gated positron emission tomography in patients with ischemic LV dysfunction and narrow QRS. Eur J Nucl Med Mol Imaging. 2012;39:1581-91.

    Article  PubMed  Google Scholar 

  22. Delgado V, van Bommel RJ, Bertini M, Borleffs CJ, Marsan NA, Arnold CT, et al. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation. 2011;123:70-8.

    Article  PubMed  Google Scholar 

  23. Hellman RN. Gadolinium-induced nephrogenic systemic fibrosis. Semin Nephrol. 2011;31:310-6.

    Article  PubMed  Google Scholar 

  24. Kumar V, Venkataraman R, Aljaroudi W, Osorio J, Heo J, Iskandrian AE, et al. Implications of left bundle branch block in patient treatment. Am J Cardiol. 2013;111(2):291-300. doi:10.1016/j.amjcard.2012.09.029.

    Article  PubMed  Google Scholar 

Download references

Disclosures

Dr Iskandrian is a scientific advisor for Rapidscan, Pharma and has received research grants from the Astellas Pharma USA. Dr Hage has received research grants from the Astellas Pharma USA. Dr Hage is a scientific advisor for Astellas Pharma USA. The other authors report no financial disclosures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fadi G. Hage MD, FACC.

Additional information

See related editorial, doi:10.1007/s12350-014-9907-3.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aggarwal, H., AlJaroudi, W.A., Mehta, S. et al. The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease. J. Nucl. Cardiol. 21, 739–746 (2014). https://doi.org/10.1007/s12350-014-9886-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-014-9886-4

Keywords

Navigation